This inventor holds 2 USPTO granted patents. Top assignees: University of Manitoba, Albert Einstein College of Medicine. Active years: 2024-2026.
Company Filing History:
2 out of 212 
1 out of 513 
Years Active: 2024-2026
Title: Lorrie Kirshenbaum: Innovator in Cardiovascular Research
Introduction
Lorrie Kirshenbaum is a prominent inventor based in Winnipeg, Canada. She has made significant contributions to the field of cardiovascular research, particularly through her innovative work on BAX inhibitors. Her research focuses on developing compounds that can effectively treat diseases and disorders related to cardiovascular health.
Latest Patents
Lorrie Kirshenbaum holds a patent for "Small molecule BAX inhibitors and uses thereof." This patent discloses compounds, compositions, and methods for using these compounds to inhibit BAX, which is crucial in treating cardiovascular diseases and disorders. She has been recognized for her groundbreaking work in this area, which has the potential to impact many lives.
Career Highlights
Throughout her career, Lorrie has worked at esteemed institutions such as the Albert Einstein College of Medicine and the University of Manitoba. Her experience in these organizations has allowed her to collaborate with leading experts in the field and further her research endeavors.
Collaborations
Lorrie Kirshenbaum has collaborated with notable colleagues, including Thomas P. Garner and Richard N. Kitsis. These partnerships have enriched her research and contributed to the advancement of knowledge in cardiovascular health.
Conclusion
Lorrie Kirshenbaum is a trailblazer in the field of cardiovascular research, with her innovative patents and collaborations paving the way for future advancements. Her work continues to inspire and influence the scientific community.